Galectin 3 protects from cisplatin-induced acute kidney injury by promoting TLR-2-dependent activation of IDO1/Kynurenine pathway in renal DCs

Strategies targeting cross-talk between immunosuppressive renal dendritic cells (DCs) and T regulatory cells (Tregs) may be effective in treating cisplatin (CDDP)-induced acute kidney injury (AKI). Galectin 3 (Gal-3), expressed on renal DCs, is known as a crucial regulator of immune response in the...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Theranostics
Auteurs principaux: Volarevic, Vladislav, Markovic, Bojana Simovic, Jankovic, Marina Gazdic, Djokovic, Bojana, Jovicic, Nemanja, Harrell, C. Randall, Fellabaum, Crissy, Djonov, Valentin, Arsenijevic, Nebojsa, Lukic, Miodrag L.
Format: Artigo
Langue:Inglês
Publié: Ivyspring International Publisher 2019
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6735380/
https://ncbi.nlm.nih.gov/pubmed/31534532
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.33959
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires